Pricing Log in Create free account

Compugen Ltd. (CGEN) vs Niagen Bioscience, Inc. (NAGE)

Compugen Ltd. and Niagen Bioscience, Inc. are both Biotechnology companies. Compugen Ltd. and Niagen Bioscience, Inc. are of similar size ($204.2M and $197.0M). Compugen Ltd. trades at the lower P/E: 5.2× against 12.5×. Compugen Ltd. grew revenue faster over the last twelve months: 234.2% against 11.0%. Compugen Ltd. has the higher net margin (47.6% vs 12.4%) and the lower return on invested capital (0.00% vs 42.0%). Across the 20 metrics below, Compugen Ltd. leads on 17 and Niagen Bioscience, Inc. on 3.

Valuation

Metric CGEN NAGE Biotechnology median
P/E 5.16 12.45 8.50
P/S 2.51 1.53 9.71
P/B 2.09 2.39 2.13
Price to free cash flow 4.63 17.24 20.82
EV/EBITDA 1.99 11.46 0.64
EV/Sales 0.81 1.03 9.21
Earnings yield 19.39% 8.03% (33.15%)
Free cash flow yield 21.58% 5.80% (25.50%)

Profitability

Metric CGEN NAGE Biotechnology median
Gross margin 86.89% 64.24% 65.16%
Operating margin 40.94% 8.21% 0.00%
Net margin 47.55% 12.39% 0.00%
Free cash flow margin 54.10% 8.89% 0.00%
Return on equity 47.85% 21.80% (56.36%)
Return on assets 23.86% 16.14% (48.04%)
Return on invested capital 0.00% 41.95% 0.00%

Growth

Metric CGEN NAGE Biotechnology median
Revenue growth (TTM) 234.18% 10.99% 6.02%
EPS growth (last fiscal year) 337.50% 81.82% 30.26%
Revenue growth, 5-year CAGR 105.20% 16.91% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGEN NAGE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.72 6.50 4.72
Net debt to EBITDA (4.65) (3.80) 0.96

Dividend

Metric CGEN NAGE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CGEN NAGE Biotechnology median
Market cap 197.04m 204.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack